Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
British Journal of Pharmacology|May 1, 1995
Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivoF Bertolino, J P Valentin, M Maffre, et al.
Breast Cancer Research and Treatment|June 3, 2018
The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcomeH Arias-Pulido, A Cimino-Mathews, N Chaher, et al.
Biochemical Pharmacology|February 28, 2001
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in cultureD Junquero, A Pilon, E Carilla-Durand, et al.
British Journal of Pharmacology|January 22, 2009
Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonistA Newman-Tancredi, J-C Martel, M-B Assié, et al.
Breast (Edinburgh, Scotland)|September 5, 2020
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancerC Van Berckelaer, M Van Geyt, S Linders, et al.
Neuropharmacology|November 9, 2002
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesiaF C Colpaert, J P Tarayre, W Koek, et al.
European Radiology|March 17, 2004
Preoperative breast MRI in patients with invasive lobular breast cancerK Schelfout, M Van Goethem, E Kersschot, et al.
Breast Cancer Research : BCR|February 20, 2019
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expressionC Van Berckelaer, C Rypens, P van Dam, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potentialW Koek, J F Patoiseau, M B Assié, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2004
Contrast-enhanced MR imaging of breast lesions and effect on treatmentK Schelfout, M Van Goethem, E Kersschot, et al.
Pageof 24